Pfizer-BioNTech testing booster of their COVID-19 vaccine in new trial
They are also in talks with regulatory authorities about testing a vaccine modified to protect specifically against the highly transmissible new variant found in South Africa and elsewhere, known as B.1.351, as a second arm of the same study.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: African Health | Biotechnology | COVID-19 | Pfizer | Pharmaceuticals | South Africa Health | Study | Vaccines